Lungpacer Medical, Inc. is an early-stage medical device company founded in May 2009 and currently headquartered at the Simon Fraser University (SFU) Campus in Burnaby, British Columbia. The objective of the company is to develop and commercialize a novel therapeutic solution that addresses five significant issues associated with mechanical ventilation of critically ill patients.
Intravenously inserted Lungpacer electrodes rhythmically activate the diaphragm. Pacing prevents diaphragm muscle-disuse atrophy, resulting in faster patient recovery, a shorter stay in intensive care, lower hospitalization costs and greater patient access to scarce mechanical ventilators during flu pandemics.